Graematter has developed a patented regulatory intelligence system that integrates data from more than 100 FDA-related databases into a single searchable database. The product provides advanced search capabilities that the company says shorten searches from days or weeks to under two hours and reduce the chance of missing critical information. Graematter's mission is to accelerate getting innovative medical products to patients by improving regulatory intelligence and the quality of regulatory submissions. The company was selected to showcase its technology at the 2012 HHS Datapalooza. Graematter is an early-stage information-technology venture headquartered in St. Louis, Missouri, led by founder Melissa Walker and CEO Merle Symes. The company expects to launch the product into the market by mid-2013.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

May 2013